Healthcare -
Biotechnology - NASDAQ - US
$ 32.775
-6.65 %
$ 200 M
Market Cap
-16.55
P/E
MNPR - STOCK-BASED COMPENSATION
Stock-based Compensation MNPR - Monopar Therapeutics Inc.
1.9 M
LAST VALUE
13.70%
2 YEAR CAGR
29.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR